This open-label, randomized study will compare the efficacy, safety, and acceptability of mifepristone 200 mg followed in 24-36 hours either by buccal (i.e., in the cheeks) or oral misoprostol 800 mcg for termination of pregnancy in women up to 63 days L.M.P.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
1,200
Family Planning Associates Medical Group
Chicago, Illinois, United States
Planned Parenthood League of Massachusetts (Boston clinic)
Boston, Massachusetts, United States
Columbia University Medical Center, Division of Obstetrics & Gynecology
New York, New York, United States
efficacy
acceptability
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Institute for Urban Family Health
New York, New York, United States
Parkmed
New York, New York, United States
University of Pittsburgh, Division of Obstetrics, Gynecology and Reproductive Sciences
Pittsburgh, Pennsylvania, United States
Whole Women's Health
Austin, Texas, United States
Planned Parenthood
Waco, Texas, United States